Y-mAbs is a late-stage clinical biopharmaceutical company focused on the development and commercialization of novel, antibody-based therapeutic products for the treatment of cancer.
Sutro Biopharma
3 followers
Active Motif
3 followers
Dyno Therapeutics
4 followers
Janux Therapeutics
1 follower
Eikon Therapeutics
3 followers
Gilead Sciences
159 followers
Regeneron
130 followers
Illumina
79 followers
Agilent Technologies
81 followers
Verily Life Sciences
45 followers
Alexion Pharmaceuticals
44 followers
Explore companies